CAS 148580-25-0
:5,12-Naphthacenedione,7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[[[[4-(b-D-glucopyranuronosyloxy)-3-nitrophenyl]methoxy]carbonyl]amino]-a-L-lyxo-hexopyranosyl]oxy]-,(8S,10S)- (9CI)
Description:
5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[[[[4-(b-D-glucopyranuronosyloxy)-3-nitrophenyl]methoxy]carbonyl]amino]-a-L-lyxo-hexopyranosyl]oxy]-, (8S,10S)- (9CI), with the CAS number 148580-25-0, is a complex organic compound characterized by its intricate molecular structure, which includes multiple hydroxyl groups, a methoxy group, and various sugar moieties. This compound is notable for its potential biological activity, often studied for its pharmacological properties. The presence of multiple functional groups suggests it may engage in various chemical interactions, making it a candidate for research in medicinal chemistry. Its stereochemistry, indicated by the (8S,10S) configuration, is crucial for its biological activity, as the spatial arrangement of atoms can significantly influence how the molecule interacts with biological targets. Overall, this compound exemplifies the complexity and diversity of organic molecules used in pharmaceutical applications.
Formula:C41H42N2O22
Synonyms:- 5,12-Naphthacenedione,7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[[[[4-(b-D-glucopyranuronosyloxy)-3-nitrophenyl]methoxy]carbonyl]amino]-a-L-lyxo-hexopyranosyl]oxy]-,(8S-cis)-
- F 826
- Hmr 1826
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
HMR 1826
CAS:HMR 1826 is an analog of a medicinal compound that has been shown to have potent anticancer activity. It is a protein kinase inhibitor that induces apoptosis in cancer cells, particularly those of Chinese origin. HMR 1826 has been shown to be effective against a variety of tumors, and it works by inhibiting kinases involved in cell growth and division. In addition, HMR 1826 has been found to be present in human urine, which suggests that it may have potential as a diagnostic tool for cancer. The development of HMR 1826 and other kinase inhibitors represents an exciting new approach to the treatment of cancer, and ongoing research continues to investigate their potential therapeutic applications.
Formula:C41H42N2O21Purity:Min. 95%Molecular weight:898.8 g/mol
